Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, has officially launched its All-in-One Women’s Health CRO” offering of contract research organization (CRO) and technology solutions, designed to run clinical trials for women’s health products.
To understand the significance behind such a development, we first must acknowledge how women actually are actually at an increased risk of developing certain diseases like breast cancer, osteoporosis, autoimmune disorders, and more. Not just that, due to hormone fluctuations, reproductive health, and other biological factors, they may also experience very different treatment responses to medications than men.
Keeping that in mind, Lindus Health’s “All-in-One Women’s Health CRO” solution harnesses its comprehensive CRO and site services.
Built on the company’s extensive experience in operating women’s health clinical trials, the stated is equipped with an assortment of multi-pronged recruitment tactics that include screening a repository of over 30 million electronic health records (EHRs), digital marketing, collaborations with primary care, women’s health clinics, and community groups. These tactics, on their part, enable sponsors to recruit diverse cohorts of participants twice as fast as traditional CROs in all study environments, including site-based, hybrid, and fully virtual settings.
Talk about the given solution on a slightly deeper level, we begin from its promise of providing end-to-end CRO services that ensure, right from study initiation to completion, Lindus’ clinical operations team is able to manage all project-related and administrative activities for women’s health trials.
Next up, we have the prospect of accessing a flexible eClinical platform i.e. Citrus, Lindus’ proprietary clinical research management technology designed for each individual study. This particular platform can tread up a long distance to help you integrate essential tools, such as clinical trial management software (CTMS), electronic data capture (EDC), telehealth, eConsent, and much more, all for the purpose of providing everything needed to achieve an efficient brand of clinical trial management.
“Women have historically been underrepresented in clinical research, resulting in significant treatment disparities,” said Emma Ogburn, Vice President of Clinical Operations of Lindus Health. “Here at Lindus, it’s paramount that we help sponsors develop safe and reliable therapies for women by enrolling diverse, representative study populations while taking into account the unique aspects of their biology.”
Joining the mix would an expansive pool of industry and regulatory knowledge. In essence, Lindus will leverage its new solution to offer expert guidance in regards to regulatory requirements and industry trends relevant to the women’s health market segment.
Finally, our last piece of highlight is rooted in the new solution’s robust site services. More on the same would reveal how Lindus’ site operations team will collaborate closely with principal investigators (PIs) and research teams to successfully manage women’s health trials across various formats, including single-site, multi-site, virtual/hybrid, and traditional setups.
Making this Innovation even more important, though, is the fact that, till date, Lindus Health has enrolled over 2,500 patients in women’s health clinical trials across the US, UK, and Europe. The company has markedly done so to address a range of medical conditions, including diabetes, asthma, acne, social anxiety, major depressive disorder, hypertension, chronic fatigue syndrome and insomnia.
“Lindus has been a great partner in helping us conduct our clinical research,” said Dr. Navid Khodaparast, Chief Scientific Officer at Spark Biomedical. “Their clear communication and proactive approach of handling all the ‘what ifs’ sets them apart from other CROs we’ve worked with. We really enjoy collaborating with them.”